- CA$316.32m
- CA$283.38m
- CA$52.51m
- 94
- 30
- 80
- 75
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 10.2 | 13.8 | 24.7 | 40 | 52.5 |
Cost of Revenue | |||||
Gross Profit | 7.47 | 10.3 | 19.4 | 32.9 | 42.8 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 11.3 | 15.8 | 26.2 | 38.6 | 47.6 |
Operating Profit | -1.1 | -2.04 | -1.56 | 1.38 | 4.91 |
Total Net Non Operating Interest Income / Expense | |||||
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -1.68 | -2.13 | -1.61 | 1.31 | 5.33 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.626 | -2.17 | -1.95 | 1.21 | 4.55 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.626 | -2.17 | -1.95 | 1.21 | 4.55 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.626 | -2.17 | -1.95 | 1.21 | 4.55 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.007 | -0.043 | -0.032 | 0.082 | 0.126 |